Results of evaluation of the effect of the photodynamic therapy for involutional changes on anxiety indicators
- Authors: Beimanova M.A.1, Petunina V.V.2
-
Affiliations:
- Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Healthcare Department
- Pirogov Russian National Research University
- Issue: Vol 31, No 4 (2024)
- Pages: 176-181
- Section: Dermatology/allergology
- URL: https://bakhtiniada.ru/2073-4034/article/view/270900
- DOI: https://doi.org/10.18565/pharmateca.2024.4.176-181
- ID: 270900
Cite item
Open Access
Access granted
Subscription Access
Abstract
Objective. Evaluation of the effect of photodynamic therapy (PDT) with Chlorin E6-based photosensitizer (PS) used for the correction of involutional skin changes, on anxiety in a group of patients with a history of basal cell carcinoma (BCC) or actinic keratosis (AK).
Methods. 90 patients with a history of skin tumors were followed-up. Patients were stratified into two groups, the first included women aged 50–60 years, the second – women over 61 years of age. The PS «Khloderm» was used in this work. The patients’ anxiety scores were assessed using Spielberger-Khanin questionnaires. Additionally, questions about personal fear about cancer, fear of loss of external attractiveness were introduced.
Results. In the group of patients over 60 years of age with a history of of non-melanocytic neoplasms, PDT statistically significantly reduced the proportion of high anxiety levels. The levels of situational anxiety after a course of PDT changed, showing a statistically significant increase in the proportion of patients with a low anxiety level – from 42.2 to 66.7. An analysis of the patients’ personal fears after correction using PDT showed that the proportion of women who indicated a fear of loss of external attractiveness significantly decreased from the initial values in the group of patients under 60 years of age. After 1 year after PDT, the proportion of patients who experienced fear of loss of external attractiveness significantly decreased from the baseline, not only in the subgroup under 60 years of age, but also over 60 years of age, which may reflect the accumulated effect of PDT.
Conclusion. Against the background of PDT using LED lamps for the correction of involutional changes, there was a decrease in the indicators of personal fears of patients in terms of both loss of external attractiveness with age and fears associated with the underlying disease, which can be regarded as a normalization of the psychological aspect of quality of life in the presence of a burdened history of cancer.
Full Text
##article.viewOnOriginalSite##About the authors
Maria A. Beimanova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Healthcare Department
Author for correspondence.
Email: beimanova@mail.ru
ORCID iD: 0000-0003-4020-7834
Postgraduate Student at the department
Russian Federation, MoscowV. V. Petunina
Pirogov Russian National Research University
Email: beimanova@mail.ru
ORCID iD: 0000-0002-3808-8584
Russian Federation, Moscow
References
- Depp C.A., Davis C.E., Mittal D., et al. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry. 2006;67(2):215–21. doi: 10.4088/jcp.v67n0207.
- Phelan E.A., Larson E.B. «Successful aging»– where next? J Am Geriatr Soc. 2002;50(7):1306–308. doi: 10.1046/j.1532-5415.2002.t01-1-50324.x.
- Bhatt N., Agrawal S., Mehta K. Risk factors and self-perception for facial aging among Nepalese population. J Cosmet Dermatol. 2019;18(6):1794–99. doi: 10.1111/jocd.12885.
- Tobin D.J. Introduction to skin aging. J Tissue Viability. 2017;26(1):37–46. doi: 10.1016/j.jtv.2016.03.002.
- Shah A.R., Kennedy P.M. The Aging Face. Med Clin North Am. 2018;102(6):1041–54. doi: 10.1016/j.mcna.2018.06.006.
- Филоненко Е.В. Флуоресцентная диагностика и фотодинамическая терапия в онкологии. Российский биотерапевтический журнал. 2013;2:85–5a. [Filonenko E.V. Fluorescence diagnostics and photodynamic therapy: justification of applications and opportunities in oncology. Rossiyskiy bioterapevticheskiy zhurnal. 2013; 2:85–5a. (In Russ)].
- Kohl E., Torezan L.A., Landthaler M., Szeimies R.M. Aesthetic effects of topical photodynamic therapy. J Eur Acad Dermatol Venereol. 2010;24(11):1261–69. doi: 10.1111/j.1468-3083.2010.03625.x.
- Glass G.E. Photobiomodulation: The Clinical Applications of Low-Level Light Therapy. Aesthet Surg J. 2021;41(6):723–38. doi: 10.1093/asj/sjab025.
- Hennessy M., Hamblin M.R. Photobiomodulation and the brain: a new paradigm. J Opt. 2017;19(1):013003. doi: 10.1088/2040-8986/19/1/013003.
- Шепитько В.И., Ерошенко Г.А., Лисаченко О.Д. Возрастные аспекты строения кожи лица человека. Мир медицины и биологии. 2013;3-2:91–7. [Shepit’ko V.I., Eroshenko G.A., Lisachenko O.D. Age aspects of the structure of human facial skin. Mir meditsiny i biologii. 2013;3-2:91–7. (In Russ.)].
- Батыршина С.В. Кожа и женские половые гормоны. Влияние заместительной гормональной терапии на состояние кожи. Практическая медицина. 2015;86(1):11–5. [Batyrshina S.V. Skin and female sex hormones. Effect of hormonal replacement therapy on the skin. Prakticheskaya meditsina. 2015;86(1):11–5. (In Russ.)].
- Спилбергер Ч. Концептуальные и методологические проблемы исследования тревоги. СПб.: Питер, 2001. [Spilberger Ch. Conceptual and methodological issues in anxiety research. St. Petersburg: Piter, 2001. (In Russ.)].
- Harris M., Taylor G. Medical statistics made easy. London: Taylor and Francis, 2003. doi: 10.3109/9780203502778.
- Kohl E., Torezan L.A., Landthaler M., Szeimies R.M. Aesthetic effects of topical photodynamic therapy. J Eur Acad Dermatol.Venereol. 2010;24(11):1261–69. doi: 10.1111/j.1468-3083.2010.03625.x.
- Waalboer-Spuij R., Nijsten T.E. A review on quality of life in keratinocyte carcinoma patients. G Ital Dermatol Venereol. 2013;148(3):249–54.
- Themstrup L., Jemec G.E., Lock-Andersen J. Patients highly value routine follow-up of skin cancer and cutaneous melanoma. Dan Med J. 2013;60(10):A4713.
- Askalsky P., Iosifescu D.V. Transcranial photobiomodulation for the management of depression: current perspectives. Neuropsychiatr Dis Treat. 2019;15:3255–72.
Supplementary files
